http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10236953-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1997-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fca50674f7a78cdc058f1827a1e6e5d0 |
| publicationDate | 1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H10236953-A |
| titleOfInvention | p21 inducer |
| abstract | (57) [Summary] (Modified) [Solution] General formula below [In the formula, R represents a benzoyl group which may have a lower alkoxy group as a substituent on the phenyl ring. The carbon-carbon bond between the 3-position and the 4-position of the carbostyril skeleton indicates a single bond or a double bond. ] A p21-inducing agent comprising as an active ingredient at least one compound selected from the carbostyril derivatives represented by the formula: [Effect] The above-mentioned p21 inducer is based on the induction effect, For example, it is effective for prevention and treatment of Sjogren's syndrome, autoimmune pancreatitis, SLE, and the like. |
| priorityDate | 1997-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.